Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Leukemia 16Carcinoma, Renal Cell 15Leukemia, Myeloid, Chronic-Phase 13Kidney Neoplasms 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Melanoma 8Multiple Myeloma 7Pancreatic Neoplasms 6Lymphoma 6Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Carcinoma, Hepatocellular 4Waldenstrom Macroglobulinemia 3Urinary Bladder Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Stomach Neoplasms 2Skin Neoplasms 2Recurrence 2Polycythemia Vera 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Interferon-alpha × Clear all
NCT00019474 2018-09-14

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

Montefiore Medical Center

Phase 2 Completed
60 enrolled
Gastrointestinal

Bile Duct Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT01681446 2018-06-01

Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression

Fudan University

Phase 3 Unknown
296 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00838968 2012-08-23

The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma

Fudan University

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT00250796 2010-01-07

Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma

University of New Mexico

Phase 2 Completed
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡